#SFHS2609376ADecree of April 10, 2026, Amending the Decree of April 12, 2022, Setting the List of Medicine Classes for Hybrid Group Register
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This French law updates the classification of medicines eligible for inclusion in the hybrid group register. It adds several therapeutic classes, such as laxatives and anti-acne preparations, while removing otological anti-infective drugs. Pharmacists, medical professionals, and pharmaceutical companies need to note these changes for regulatory and procurement purposes.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Addition of therapeutic classes such as laxatives and anti-acne preparations to the register
- Removal of otological anti-infective drugs from the register
Obligations
What this law requires
Add the following ATC medicine classes to the hybrid group register list: A06AD (osmotic laxatives), D03A (wound and ulcer treatments), D04A (antipruritic agents), D06A (topical antibiotics for dermatological use), D07 (dermatological corticosteroids), D10A (topical anti-acne preparations), G01A (gynecological anti-infectives and antiseptics excluding corticosteroid combinations), M02A (topical products for articular and muscular pain), R01A (nasal decongestants and topical nasal preparations), and S02 (otological medicines)
Remove ATC class S02A (otological anti-infective medicines) from the hybrid group register list
Update internal medicine classification systems and procurement procedures to reflect the newly added therapeutic classes eligible for hybrid group registration
Ensure medicines previously registered under S02A (otological anti-infectives) are no longer included in hybrid group registrations effective from the decree's entry into force
Publish this decree in the French Official Journal (Journal officiel de la République française)